10-Q: HealthLynked Corp. Reports Q2 2024 Results with Revenue Decline and Increased Net Loss

HealthLynked Corp. reported a significant year-over-year revenue decrease and an increased net loss for the second quarter of 2024, primarily due to reduced patient service revenue and increased debt-related expenses.

Summary

• HealthLynked Corp. reported a net loss of $1.54 million for the three months ended June 30, 2024, compared to a net loss of $1.00 million for the same period in 2023.
• The company's total revenue decreased by 53% year-over-year, from $1.70 million to $0.79 million, with patient service revenue declining by 53% due to reduced clinical staffing and practice attrition.
• Operating expenses decreased by 25% year-over-year, primarily due to cost reduction efforts in practice salaries and other operating costs.
• The company's loss from operations increased by 35% year-over-year, from $0.79 million to $1.08 million, due to the significant revenue decline.
• Other expenses increased significantly due to higher amortization of debt discounts and losses on debt extinguishment.
• For the six months ended June 30, 2024, the company's net loss was $2.93 million, compared to a net income of $0.45 million for the same period in 2023, which included a gain from the sale of a discontinued operation.
• The company's cash balance as of June 30, 2024, was $172,700, with a working capital deficit of $1.39 million and an accumulated deficit of $44.96 million.
• The company used $1.71 million in cash from operating activities during the first six months of 2024.
• Management has expressed substantial doubt about the company's ability to continue as a going concern without additional funding.

Sentiment

Score: 2

Explanation: The document indicates a very negative outlook due to significant revenue decline, increased net loss, low cash balance, and management's doubt about the company's ability to continue as a going concern. The company's reliance on debt financing and the lack of profitability in its digital healthcare segment further contribute to the negative sentiment.

Positives

• Operating expenses decreased by 25% year-over-year in Q2 2024, indicating successful cost reduction efforts.
• Depreciation and amortization expenses decreased slightly, reflecting the end of depreciable lives for some assets.

Negatives

• Patient service revenue decreased by 53% year-over-year in Q2 2024, indicating significant challenges in maintaining revenue streams.
• Total revenue decreased by 53% year-over-year in Q2 2024, highlighting a substantial decline in overall business activity.
• Loss from operations increased by 35% year-over-year in Q2 2024, indicating a worsening operational performance.
• Amortization of original issue discounts on notes payable increased by 189% year-over-year in Q2 2024, reflecting increased debt financing costs.
• Net loss increased by 54% year-over-year in Q2 2024, demonstrating a significant deterioration in profitability.
• The company has a working capital deficit of $1.39 million as of June 30, 2024, indicating a precarious financial position.
• The company used $1.71 million in cash from operating activities during the first six months of 2024, highlighting cash flow challenges.
• Management has expressed substantial doubt about the company's ability to continue as a going concern without additional funding.

Risks

• The company's ability to continue as a going concern is in doubt without additional funding.
• The company is dependent on outside sources of capital to fund its operations.
• The company faces uncertainty related to product development and revenue generation from its Digital Healthcare Division.
• The company's reliance on a single supplier for its Medical Distribution Division poses a risk to its supply chain.
• The company's financial results are subject to the impact of geopolitical events, such as the Hamas-Israel and Russia-Ukraine conflicts.
• The company's revenue is highly dependent on clinical staffing levels, which have seen recent departures.
• The company's ability to achieve profitability is dependent on future events, including obtaining adequate financing and generating sufficient revenue.

Future Outlook

The company expects patient service revenue to increase in future periods as they plan to add additional physicians and continue patient marketing and retention efforts, but there is no guarantee that such increases will occur. The company plans to raise additional capital to fund its ongoing plan of operation.

Management Comments

• Management has evaluated the significance of the conditions described above in relation to the Company's ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the consolidated financial statements were issued.
• Management considered the Company's current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company's obligations due before August 14, 2025.

Industry Context

The healthcare industry is facing challenges related to staffing shortages and changing patient preferences, which are reflected in HealthLynked's revenue decline. The company's focus on digital healthcare and medical distribution aligns with broader industry trends towards technology adoption and cost-effective solutions.

Comparison to Industry Standards

• HealthLynked's revenue decline of 53% in Q2 2024 is significantly worse than the average performance of comparable healthcare service providers, which have seen modest growth or slight declines in revenue.
• The company's net loss of $1.54 million in Q2 2024 is also substantially worse than the average profitability of similar companies, many of which are reporting positive earnings or smaller losses.
• The company's cash balance of $172,700 is significantly lower than the industry average, indicating a higher risk of financial distress.
• The company's reliance on debt financing and the high amortization of debt discounts are not typical for established healthcare companies, suggesting a higher level of financial risk.
• Compared to companies like Teladoc Health (TDOC) or Amwell (AMWL), which are focused on telehealth, HealthLynked's digital healthcare segment is not yet generating significant revenue, indicating a slower adoption rate or less effective marketing strategy.
• Unlike larger medical supply distributors such as McKesson (MCK) or Cardinal Health (CAH), HealthLynked's medical distribution segment is experiencing declining revenue, suggesting a lack of scale or competitive pricing.

Legal Proceedings

• The company is not aware of any legal proceedings that will have a material adverse effect on its business, financial condition, or operating results.

Related Party Transactions

• The company issued multiple convertible notes payable to its CEO, Dr. Michael Dent, for aggregate net cash proceeds of $1,650,000.
• The company refinanced an existing note with a principal of $166,500 with a new convertible note payable to Dr. Dent.
• Consulting fees paid by the company to Dr. Dent's spouse were $33,462 and $72,500 in the three and six months ended June 30, 2024, respectively.
• Outside directors receive compensation equal to $20,000 in shares of restricted stock per annum.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and the substantial doubt about its ability to continue as a going concern.
• Employees may experience uncertainty due to the company's financial challenges and potential restructuring.
• Customers may be affected by potential changes in service offerings or availability due to the company's financial difficulties.
• Suppliers may face increased risk of non-payment or delayed payments due to the company's financial instability.
• Creditors face increased risk of default due to the company's financial challenges and reliance on debt financing.

Next Steps

• The company plans to add additional physicians and continue patient marketing and retention efforts to increase patient service revenue.
• The company intends to raise additional capital to fund its ongoing plan of operation.
• The company will continue to market the HealthLynked Network to large health systems, hospitals, and universities.
• The company will leverage MOD's discounted medical supplies as an offering to its patient and physician members in the HealthLynked Network.
• The company intends to utilize physician telesales through the use of telesales representatives.

Key Dates

Keywords

HealthLynked, financial results, revenue decline, net loss, operating expenses, debt financing, going concern, healthcare, digital healthcare, medical distribution, patient service revenue, clinical staffing